DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Blohmer JU, Link T, Kümmel S. et al.
Investigating denosumab as an add-on treatment to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer – First results of the GeparX study.
SABCS 2019; GS3-01
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.